• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Atria

16.06 EUR+0.63 %17.8, 17.29
5,718 following

ATRAV

NASDAQ Helsinki

Food & Beverage

Consumer Goods & Services

Overview
Financials & Estimates
Dividend
Investor consensus
Compare
+0.63 %
+2.82 %
+12.46 %
-6.63 %
+4.97 %
+25.47 %
+69.05 %
+30.57 %
+87.23 %

Atria is a food group. The group includes several players, the better known of which include Sibylla, Lithells and Ridderheims. The subsidiaries' operations include the production of liver pâté, meat and chicken products, and various finished products. The operations are conducted on a global level, mainly concentrated in the Nordic countries, the Baltics and Russia. The company was founded in 1903 and has its headquarters in Seinäjoki.

Read more
Market cap
453.98M EUR
Turnover
27.02K EUR
P/E (adj.) (26e)
9.08
EV/EBIT (adj.) (26e)
9.3
P/B (26e)
0.99
EV/S (26e)
0.37
Dividend yield-% (26e)
4.86 %
Coverage
Recommendation
Accumulate
Target price
19.00 EUR
Updated
22.07.2026
Disclaimer
Pauli Lohi
Pauli Lohi

Analyst

Latest research

Latest analysis report

Released: 22.07.2026

Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
3rd party
ShowingAll content types

Forum discussions
Here are Pauli’s comments on the Q2 result Atria reported its Q2 results today, which were stronger than expected in terms of both growth and profitability. The figures were boosted by a successful start to the grilling season. The company mentions that cost pressure began to rise...
7/22/2026, 7:13 AM
by Sijoittaja-alokas
5
Rauli & Pauli Corporation have released a company report on Atria Despite inflationary pressures, we believe Atria’s earnings will remain approximately at the level of the comparison period this year. Following the share price decline, the company’s valuation (e.g., 2026 P/E and ...
6/5/2026, 5:12 AM
by Sijoittaja-alokas
5
Here are Pauli’s comments on Atria’s release regarding the impacts of swine fever. Inderes – 7 Aug 26 Atria: Sikaruton vaikutukset merkittävät, tulos kasvaa silti - Inderes Yhtiö piti ennallaan nousujohteisen tulosohjeistuksen merkittävästä haitasta huolimatta.
8/7/2026, 8:10 AM
by Sijoittaja-alokas
3
Swine fever has arrived in Finland. - Ruohola estimates that the biggest problems are related to the Chinese and Japanese markets. “It looks like the export ban to China and Japan could last for up to three years. This is a big blow to Finland’s pig farming industry and also to us...
7/30/2026, 4:44 PM
by Sheikki
3
Here is a new company report on Atria from Pauli following the Q2 results Q2 strengthened our confidence in the company’s earnings growth through both the actual figures and the progress made in its strategy. The effects of cost inflation will intensify in H2, but we believe the ...
7/22/2026, 10:21 PM
by Sijoittaja-alokas
3
Here are Pauli’s comments on African swine fever and its impact on Atria and HKFoods African swine fever found in Finnish wild boars will have a negative impact on the export opportunities of the domestic meat industry. An interruption in pork exports to Asia could reduce the companies...
7/31/2026, 8:31 AM
by Sijoittaja-alokas
2
A huge blow to the Finnish meat industry "Atria has activated its contingency plan and is currently not packing products for countries affected by the ASF suspicion regarding exports. According to Hirvijärvi, many Asian countries have a strict stance on African swine fever. According...
7/30/2026, 5:42 PM
by JTN
1
Read more on our forum
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
22.10
2026

Interim report Q3'26

12.2
2027

Annual report '26

22.4
2027

General meeting '27

Third party research07.08.2026, 08.34

Atria: Negative impact from ASF above our earlier thinking - Nordea

Atria expects EUR -7m annualised EBIT impact to its Finnish export business from ASF outbreak in Finland. The company assumes that exports to China and Japan will be discontinued while pork sales to South Korea will continue. Atria expects EUR 4-5m negative...

Atria
Atria: Betydelige konsekvenser af svinepest, men resultatet vokser stadig
Analyst Comment07.08.2026, 08.13 by
Pauli Lohi

Atria: Betydelige konsekvenser af svinepest, men resultatet vokser stadig

Selskabet fandt, at den positive resultatprognose var uændret på trods af en betydelig ulempe.

Atria
Regulatory press release07.08.2026, 07.30

Atria Oyj: Estimated impact of the ASF findings in Finland on Atria's result

Atria

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Third party research31.07.2026, 08.29

Asia: First ASF case in Finland will impact export opportunities - Nordea

Based on its preliminary results, Finnish Food Authority has found African Swine Fever (ASF) in Finland from a wild boar. This is the first ever case in Finland and will likely impact export opportunities to, especially Asia. For Atria, ASF could pause...

Atria
Analyst Comment31.07.2026, 10.47 by
Pauli Lohi

Atria and HKFoods: Discovery of swine fever weakens export revenues

The interruption of exports could weaken earnings by an estimated 3-5%.

HKFoodsAtria
Third party research23.07.2026, 07.08

Atria: Strong start to the grilling season - Nordea

Atria's Q2 adjusted EBIT of EUR 20.7m was 15% above LSEG Data & Analytics consensus and sales were 1% above. The company noted a strong start to the grilling season, while cost inflation started to intensify towards the end of the quarter. However, we...

Atria
Atria Q2'26: Resultatet vokser, og langsigtede projekter skrider fremad
Research22.07.2026, 19.03 by
Pauli Lohi

Atria Q2'26: Resultatet vokser, og langsigtede projekter skrider fremad

Vi ser adskillige interessante vækstmuligheder i Sverige.

Atria
Third party research22.07.2026, 08.26

Atria: Strong Q2 driven by Finland - Nordea

Atria reported Q2 adjusted EBIT of EUR 20.7m, 15% above LSEG Data & Analytics consensus. Q2 net sales of EUR 481m were up 5% y/y and came 1% above consensus. Sweden and Denmark & Estonia EBIT were slightly ahead of our expectation while Finland beat ...

Atria
Atria Q2'26 - kort kommentar: Vækst i Finland førte til et stærkt resultat
Analyst Comment22.07.2026, 07.40 by
Pauli Lohi

Atria Q2'26 - kort kommentar: Vækst i Finland førte til et stærkt resultat

Ifølge selskabet startede grillsæsonen fremragende.

Atria
Regulatory press release22.07.2026, 07.00

Half-year financial report of Atria Plc, 1 January - 30 June 2026

Atria
Atria Q2'26 preview: Mere information om inflationens effekter
Analyst Comment16.07.2026, 06.15 by
Pauli Lohi

Atria Q2'26 preview: Mere information om inflationens effekter

Hvis inflationens indvirkning på indtjeningen viser sig at være betydelig, kan dette øge risikoen for en nedjustering i slutningen af året.

Atria
Third party research15.07.2026, 10.55

Atria: Q2 2026 preview - Nordea

Ahead of Atria's Q2 report, we make only minor estimate revisions and derive a DCF- and multiples-based fair value range of EUR 18.3-22.3 (18.1-22.1). We believe the Finnish grocery market has continued on a slightly positive trajectory, while the company...

Atria
Regulatory press release24.06.2026, 13.45

Atria Oyj: Composition of Atria Plc's Nomination Board

Atria
Atria: Værdiansættelsen faldt til et attraktivt niveau, selvom inflationen presser på
Research05.06.2026, 07.00 by
Rauli Juva, Pauli Lohi

Atria: Værdiansættelsen faldt til et attraktivt niveau, selvom inflationen presser på

Som følge af kursfaldet er selskabets værdiansættelse (f.eks. 2026 P/E og EV/EBIT 9x) efter vores mening faldet til et attraktivt niveau.

Atria
Regulatory press release28.05.2026, 12.30

Atria Oyj: Atria's financial reporting in 2027

Atria
Third party research24.04.2026, 07.26

Atria: Strong top-line momentum continues - Nordea

Atria's Q1 was solid with adjusted EBIT beating LSEG Data & Analytics consensus by 6%. Higher subsidies supported the development in Estonia, while an avian influenza-driven shortage of poultry impacted sales and earnings negatively in Sweden. Ahead ...

Atria
Atria Q1'26: Omkostningsinflationen accelererer i Q2
Research24.04.2026, 06.30 by
Rauli Juva, Pauli Lohi

Atria Q1'26: Omkostningsinflationen accelererer i Q2

Vi vurderer, at den accelererende inflation tynger resultatet, og vi har derfor sænket vores estimater for indeværende år en smule.

Atria
Regulatory press release23.04.2026, 15.00

Atria Oyj: Appointments to the Supervisory Board, Board of Directors and Nomination and Remuneration Committee of Atria Plc

Atria
Regulatory press release23.04.2026, 13.45

Atria Oyj: Decisions of Atria Plc's Annual General Meeting

Atria
Atria Q1'26 - kort kommentar: Lidt bedre end forventet
Analyst Comment23.04.2026, 07.45 by
Rauli Juva

Atria Q1'26 - kort kommentar: Lidt bedre end forventet

Den stærke resultatudvikling i Sverige og Estland løftede den justerede EBIT til 13,9 MEUR, hvilket var over vores estimat.

Atria